Cargando…
Effect of cryoprecipitate transfusion without ABO group consideration: A nightmare experience
The cryoprecipitate is an essential blood product as they are rich in factor VIII, fibrinogen, von Willebrand factor, factor XIII, and fibronectin, and their volume is too small. They play a significant role in the management of massive transfusion nowadays. Usually, they are used without ABO group...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9528560/ https://www.ncbi.nlm.nih.gov/pubmed/36199410 http://dx.doi.org/10.4103/ajts.ajts_83_21 |
_version_ | 1784801325302677504 |
---|---|
author | Sahoo, Dibyajyoti Silwal, Pragya |
author_facet | Sahoo, Dibyajyoti Silwal, Pragya |
author_sort | Sahoo, Dibyajyoti |
collection | PubMed |
description | The cryoprecipitate is an essential blood product as they are rich in factor VIII, fibrinogen, von Willebrand factor, factor XIII, and fibronectin, and their volume is too small. They play a significant role in the management of massive transfusion nowadays. Usually, they are used without ABO group consideration. We here report a case in which immunohematological problems arose due to out-of-group transfusion of cryoprecipitate. We suggest that the possibility of incompatibility subsequently is to be kept in mind during transfusion of large quantity cryoprecipitate, and ABO group compatible may be preferred. |
format | Online Article Text |
id | pubmed-9528560 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-95285602022-10-04 Effect of cryoprecipitate transfusion without ABO group consideration: A nightmare experience Sahoo, Dibyajyoti Silwal, Pragya Asian J Transfus Sci Case Report The cryoprecipitate is an essential blood product as they are rich in factor VIII, fibrinogen, von Willebrand factor, factor XIII, and fibronectin, and their volume is too small. They play a significant role in the management of massive transfusion nowadays. Usually, they are used without ABO group consideration. We here report a case in which immunohematological problems arose due to out-of-group transfusion of cryoprecipitate. We suggest that the possibility of incompatibility subsequently is to be kept in mind during transfusion of large quantity cryoprecipitate, and ABO group compatible may be preferred. Wolters Kluwer - Medknow 2022 2022-07-30 /pmc/articles/PMC9528560/ /pubmed/36199410 http://dx.doi.org/10.4103/ajts.ajts_83_21 Text en Copyright: © 2022 Asian Journal of Transfusion Science https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Case Report Sahoo, Dibyajyoti Silwal, Pragya Effect of cryoprecipitate transfusion without ABO group consideration: A nightmare experience |
title | Effect of cryoprecipitate transfusion without ABO group consideration: A nightmare experience |
title_full | Effect of cryoprecipitate transfusion without ABO group consideration: A nightmare experience |
title_fullStr | Effect of cryoprecipitate transfusion without ABO group consideration: A nightmare experience |
title_full_unstemmed | Effect of cryoprecipitate transfusion without ABO group consideration: A nightmare experience |
title_short | Effect of cryoprecipitate transfusion without ABO group consideration: A nightmare experience |
title_sort | effect of cryoprecipitate transfusion without abo group consideration: a nightmare experience |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9528560/ https://www.ncbi.nlm.nih.gov/pubmed/36199410 http://dx.doi.org/10.4103/ajts.ajts_83_21 |
work_keys_str_mv | AT sahoodibyajyoti effectofcryoprecipitatetransfusionwithoutabogroupconsiderationanightmareexperience AT silwalpragya effectofcryoprecipitatetransfusionwithoutabogroupconsiderationanightmareexperience |